Ethyl 2-(4-(hydroxymethyl)piperidin-1-yl)pyrimidine-5-carboxylate, 95.0%, 5g

1-chloro-2-(ethylsulfanyl)ethane, 98.0%, 25ml

3-METHYL-1,2,4-OXADIAZOLE-5-CARBOXYLIC ACID, 95.0%, 250mg

2-chloro-4'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]benzophenone, 97.0%, 1g

4-Amino-3,5-diiodobenzoic acid, 95.0%, 5g

N-a-(2,4-Dinitro-5-fluorophenyl)-L-alaninamide, 95.0%, 5g

2-METHANESULFONYL-3-METHYL-3H-IMIDAZO[4,5-B]PYRIDINE, 90.0%, 100mg

(2S,4R)-1-((S)-2-(5-Aminopentanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride, 98%, 500mg

Streptavidin FITC Conjugate1vial

Accessories Funnel attachments, 1000 ml, Suitable for, Art. No. EYA7.1 and EYC7.1, 1 Piece(s)

Methyl 6-chloro-2-(chloromethyl)nicotinate, 95.0%, 250mg

2-Ethoxyethanol, min. 99%, for synthesis, 5 l, alu

(2'-Methyl-[1,1'-biphenyl]-2-yl)methanamine, 95%, 1g